Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Open accessThe DOI matches its Crossref record; 621 of the 626 references it cites were found in a registry or an index.
Abstract
SUMMARY: Streptococcus pyogenes , also known as group A Streptococcus (GAS), causes mild human infections such as pharyngitis and impetigo and serious infections such as necrotizing fasciitis and streptococcal toxic shock syndrome. Furthermore, repeated GAS infections may trigger autoimmune diseases, including acute poststreptococcal glomerulonephritis, acute rheumatic fever, and rheumatic heart disease. Combined, these diseases account for over half a million deaths per year globally. Genomic and molecular analyses have now characterized a large number of GAS virulence determinants, many of which exhibit overlap and redundancy in the processes of adhesion and colonization, innate immune resistance, and the capacity to facilitate tissue barrier degradation and spread within the human host. This improved understanding of the contribution of individual virulence determinants to the disease process has led to the formulation of models of GAS disease progression, which may lead to better treatment and intervention strategies. While GAS remains sensitive to all penicillins and cephalosporins, rising resistance to other antibiotics used in disease treatment is an increasing worldwide concern. Several GAS vaccine formulations that elicit protective immunity in animal models have shown promise in nonhuman primate and early-stage human trials. The development of a safe and efficacious commercial human vaccine for the prophylaxis of GAS disease remains a high priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Upon detection of these Gram-positive pyogenic bacteria, neutrophil recruitment is critical to the resolution of infection (2).”
From Epidermal hepcidin is required for neutrophil response to bacterial infection (2019) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 621
Severe Group A Streptococcal Soft-Tissue Infections in Ontario: 1992–1996
Sharkawy, A., Low, D. E., Saginur, R., Gregson, D. B., Schwartz, B., Jessamine, P. G., Green, K., McGeer, A., & Ontario Group A Streptococcal Study Group (2002) · Clinical Infectious Diseases · doi:10.1086/338466 · Cited by 144
Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice.
Wessels, M. R., & Bronze, M. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12238 · Cited by 143
Reduced Virulence of Group A Streptococcal Tn 916 Mutants That Do Not Produce Streptolysin S
Betschel, S. D., Borgia, S. M., Barg, N. L., Low, D. E., & De Azavedo, J. C. S. (1998) · Infection and Immunity · doi:10.1128/iai.66.4.1671-1679.1998 · Cited by 142 · cited 2×
“SLS is encoded by a conserved nine-gene operon, comprised of the genes sagA to sagI (SLS-associated gene), which is responsible for the characteristic zone of beta-hemolysis surrounding GAS colonies on the surface of blood agar medium (229, 230).”
BackgroundRakonjac, J. V., Robbins, J. C., & Fischetti, V. A. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.622-631.1995 · Cited by 142
Dombek, P. E., Cue, D., Sedgewick, J., Lam, H., Ruschkowski, S., Finlay, B. B., & Cleary, P. P. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01223.x · Cited by 142
Why Have Group A Streptococci Remained Susceptible to Penicillin? Report on a Symposium
Horn, D. L., Zabriskie, J. B., AUSTRIAN, R. C., Cleary, P. P., Ferretti, J. J., Fischetti, V. A., Gotschlich, E. C., Kaplan, E. L., McCarty, M., Opal, S. M., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516375 · Cited by 141 · cited 2×
“While no streptococcal species has been found to express -lactamase activity, continued ongoing surveillance measures are recommended (489).”
BackgroundCharacterization of a novel fibronectin‐binding surface protein in group A streptococci
Kreikemeyer, B., Talay, S. R., & Chhatwal, G. S. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.mmi_17010137.x · Cited by 140 · cited 1×
“Genes with a differential presence or absence among tissue-tropic strains include cpa (encoding a type I collagen binding protein) (168), prtF1 (encoding the fibronectin binding protein PrtF1) (169), sof (encoding serum opacity factor, which contains a fibronectin binding domain) (170, 171), and prtF2 (encoding the fi…”
BackgroundBaldassarri, L., Creti, R., Recchia, S., Imperi, M., Facinelli, B., Giovanetti, E., Pataracchia, M., Alfarone, G., & Orefici, G. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00512-06 · Cited by 140 · cited 1×
“It has been suggested that GAS may escape penicillin treatment by entering epithelial cells, which are poorly penetrated by penicillin (475–477), or by forming a biofilm (478, 479), or alternatively, failure of penicillin treatment may possibly be due to the protection of GAS by other -lactamase-producing bacterial sp…”
BackgroundPost-streptococcal autoimmune disorders of the central nervous system
Snider, L. A., & Swedo, S. E. (2003) · Current Opinion in Neurology · doi:10.1097/00019052-200306000-00017 · Cited by 140
Arad, G., Levy, R., Nasie, I., Hillman, D., Rotfogel, Z., Barash, U., Supper, E., Shpilka, T., Minis, A., & Kaempfer, R. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001149 · Cited by 139
Penicillin‐Binding Protein‐Mediated Resistance in Pneumococci and Staphylococci
Chambers, H. F. (1999) · The Journal of Infectious Diseases · doi:10.1086/513854 · Cited by 139 · cited 1×
“Penicillin resistance occurs in the closely related species Streptococcus pneumoniae, where resistance is mediated by mutations that result in conformational changes in PBPs, the targets of -lactam antibiotics (482).”
BackgroundBensi, G., Mora, M., Tuscano, G., Biagini, M., Chiarot, E., Bombaci, M., Capo, S., Falugi, F., Manetti, A. G. O., Donato, P., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015693 · Cited by 139 · cited 24×
“SLO oligomerizes to form large pores ( 25 to 30 nm) in host cell membranes (220).”
BackgroundInfluentialAcute rheumatic fever. A vanishing disease in suburbia
Land, M. A. (1983) · JAMA · doi:10.1001/jama.249.7.895 · Cited by 139
The group A streptococcal virR49 gene controls expression of four structural vir regulon genes
Podbielski, A., Flosdorff, A., & Weber-Heynemann, J. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.9-20.1995 · Cited by 138
Dougherty, B. A., & van de Rijn, I. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42330-1 · Cited by 137 · cited 1×
“The membrane-associated hyaluronate synthase, encoded by the first gene in the operon, hasA, is essential for hyaluronic acid biosynthesis (196, 197) and forms the linear hyaluronic acid polymer by the alternate addition of glucuronic acid and -1,3-linked N-acetylglucosamine residues (196, 198).”
BackgroundBarnett, T. C., Liebl, D., Seymour, L. M., Gillen, C. M., Lim, J. Y., LaRock, C. N., Davies, M. R., Schulz, B. L., Nizet, V., Teasdale, R. D., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.11.003 · Cited by 137 · cited 2×
“However, expression of the secreted cysteine protease SpeB results in proteolytic clearance of autophagy components from the bacterial surface, allowing intracellular proliferation (161).”
BackgroundSelf-citationLukomski, S., Hoe, N. P., Abdi, I., Rurangirwa, J., Kordari, P., Liu, M., Dou, S.-J., Adams, G. G., & Musser, J. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.535-542.2000 · Cited by 137 · cited 1×
“SIC also contributes to epithelial cell adherence (211) and mucosal colonization (212) and binds innate immune factors, including secretory leukocyte protease inhibitor, lysozyme, human -defensin-1, and human cathelicidin antimicrobial peptide LL-37 (213– 215).”
BackgroundCole, J. N., Pence, M. A., von Köckritz-Blickwede, M., Hollands, A., Gallo, R. L., Walker, M. J., & Nizet, V. (2010) · mBio · doi:10.1128/mbio.00191-10 · Cited by 136 · cited 9×
“The expression of the M protein and hyaluronic acid cap- April 2014 Volume 27 Number 2 cmr.asm.org 273 sule enhances GAS survival within NETs by increasing bacterial resistance to the antimicrobial peptide LL-37 (201).”
BackgroundInfluentialSelf-citationStålhammar‐Carlemalm, M., Areschoug, T., Larsson, C., & Lindahl, G. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01470.x · Cited by 135 · cited 1×
“Non-M-protein antigens that have been tested in animal models include fibronectin binding protein A (FbaA) (564), protein F1/SfbI (240), serum opacity factor (SOF/SfbII) (565), fibronectin binding protein 54 (FBP54) (566), R28 protein (567, 568), streptococcal protective antigen (Spa) (569), C5a peptidase (ScpA) (570–…”
BackgroundGenome Sequence of a Nephritogenic and Highly Transformable M49 Strain ofStreptococcus pyogenes
McShan, W. M., Ferretti, J. J., Karasawa, T., Suvorov, A. N., Lin, S., Qin, B., Jia, H., Kenton, S., Najar, F. Z., Wu, H., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.00672-08 · Cited by 135
Rheumatic fever–associated Streptococcus pyogenes isolates aggregate collagen
Dinkla, K., Rohde, M., Jansen, W. T. M., Kaplan, E. L., Chhatwal, G. S., & Talay, S. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17247 · Cited by 133 · cited 2×
“Consistent with this hypothesis, several GAS M proteins, notably those associated with ARF and RHD, are known to bind collagen IV through a motif called PARF (peptide associated with rheumatic fever) (397).”
BackgroundHyaluronic Acid Synthesis Operon (has) Expression in Group A Streptococci
Crater, D. L., & van de Rijn, I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18452 · Cited by 133 · cited 1×
“hasABC synthase operon (193, 194), the capsule is a high-molecFIG 1 The arsenal of virulence factors expressed by GAS to thwart the host innate immune response.”
BackgroundGroup A Streptococcus (GAS) Carbohydrate as an Immunogen for Protection against GAS Infection
Sabharwal, H., Michon, F., Nelson, D., Dong, W., Fuchs, K., Manjarrez, R. C., Sarkar, A., Uitz, C., Viteri‐Jackson, A., Suarez, R. S. R., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/498618 · Cited by 132 · cited 1×
“Affinity-purified anti-GAC antibodies successfully opsonized three tested GAS serotypes (561), and mice immunized with GAC were protected against both intraperitoneal and intranasal GAS challenge (562).”
BackgroundEndoS and SpeB from Streptococcus pyogenes Inhibit Immunoglobulin-Mediated Opsonophagocytosis
Collin, M., Svensson, M. D., Sjöholm, A. G., Jensenius, J. C., Sjöbring, U., & Olsén, A. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.6646-6651.2002 · Cited by 132 · cited 1×
“Encoded by the ndoS gene in serotype M1 GAS strains, the endo- -N-acetylglucosaminidase of streptococci (EndoS) is a secreted endoglycosidase that hydrolyzes the chitobiose core of the asparagine-linked glycan on the heavy chain of native human IgG (247), impairing recognition by Fc receptors, complement activation, a…”
BackgroundLukomski, S., Burns, E. H., Wyde, P. R., Podbielski, A., Rurangirwa, J., Moore-Poveda, D. K., & Musser, J. M. (1998) · Infection and Immunity · doi:10.1128/iai.66.2.771-776.1998 · Cited by 131 · cited 1×
“full virulence in mouse models of invasive GAS disease (254, 255, 316, 321, 322), and covRS mutants of GAS are less able to establish infection due to enhanced capsule expression, which may explain the maintenance of the wild-type allele in the GAS population (323, 324).”
BackgroundSclA, a Novel Collagen-Like Surface Protein of Streptococcus pyogenes
Rasmussen, M., Edén, A., & Björck, L. (2000) · Infection and Immunity · doi:10.1128/iai.68.11.6370-6377.2000 · Cited by 131
Jaffe, J., Natanson‐Yaron, S., Caparon, M. G., & Hanski, E. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.6331356.x · Cited by 130
Nephritis-Associated Plasmin Receptor and Acute Poststreptococcal Glomerulonephritis
Yoshizawa, N., Yamakami, K., Fujino, M., Oda, T., Tamura, K., Matsumoto, K., Sugisaki, T., & Boyle, M. D. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130624.94920.6b · Cited by 130
Anti-inflammatory treatment for carditis in acute rheumatic fever
Cilliers, A. M., Adler, A. J., & Saloojee, H. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003176.pub3 · Cited by 129 · cited 1×
“, oral prednisone at 2 mg/kg/day for 2 weeks, with a slow taper over 4 to 6 weeks) are often used to treat patients with carditis and cardiomegaly or congestive heart failure, but the benefits of antiinflammatory therapy for cardiac outcomes remain unproven (462, 463).”
BackgroundReduced thrombin generation increases host susceptibility to group A streptococcal infection
Sun, H., Wang, X., Degen, J. L., & Ginsburg, D. (2008) · Blood · doi:10.1182/blood-2008-07-170506 · Cited by 129 · cited 1×
“Transgenic mice lacking clotting factor V, deficient for thrombin generation, or lacking fibrinogen are more susceptible to invasive disease following subcutaneous challenge with GAS (372), highlighting the protective effect of proper coagulation in GAS infection.”
BackgroundShulman, S. T., Stollerman, G. H., Beall, B., Dale, J. B., & Tanz, R. R. (2006) · Clinical Infectious Diseases · doi:10.1086/499812 · Cited by 128
Terao, Y., Kawabata, S., Nakata, M., Nakagawa, I., & Hamada, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209133200 · Cited by 128
Giovanetti, E., Brenciani, A., Lupidi, R., Roberts, M. C., & Varaldo, P. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2844-2849.2003 · Cited by 128
Evidence for Superantigen Involvement in Severe Group A Streptococcal Tissue Infections
Norrby‐Teglund, A., Thulin, P., Gan, B. S., Kotb, M., McGeer, A., Andersson, J., & Low, D. E. (2001) · The Journal of Infectious Diseases · doi:10.1086/323443 · Cited by 128 · cited 1×
“Severe GAS infections such as necrotizing fasciitis and STSS are hyperinflammatory states mediated in part by streptococcal superantigens (353).”
BackgroundThe two faces of Janus: virulence gene regulation by CovR/S in group A streptococci
Churchward, G. G. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05649.x · Cited by 127
Berggård, K., Johnsson, E., Morfeldt, E., Persson, J., Stålhammar‐Carlemalm, M., & Lindahl, G. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02664.x · Cited by 127
Beres, S. B., Sylva, G. L., Sturdevant, D. E., Granville, C., Liu, M., Ricklefs, S., Whitney, A. R., Parkins, L. D., Hoe, N. P., Adams, G. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404163101 · Cited by 127 · cited 1×
“Large-scale GAS outbreaks also occur as a result of the emergence of dominant clones, which may arise through the horizontal acquisition of DNA that encodes toxins or antibiotic resistance determinants (19, 26, 40, 103), or through more subtle genetic changes (104, 105).”
BackgroundFalugi, F., Zingaretti, C., Pinto, V., Mariani, M., Amodeo, L., Manetti, A. G. O., Capo, S., Musser, J. M., Orefici, G., Margarit, I., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/593176 · Cited by 126
Brink, W. R., Rammelkamp, C. H., Denny, F. W., & Wannamaker, L. W. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90274-4 · Cited by 125 · cited 1×
“Antibiotics shorten the clinical course of GAS pharyngitis (435); however, most signs and symptoms spontaneously resolve within 3 to 4 days, even without antibiotic treatment (436).”
BackgroundIs plasminogen deployed as a Streptococcus pyogenes virulence factor?
Walker, M. J., McArthur, J. D., McKay, F. C., & Ranson, M. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.05.006 · Cited by 125
Self-citationTreviño, J., Perez, N., Ramirez-Peña, E., Liu, Z., Shelburne, S. A., Musser, J. M., & Sumby, P. (2009) · Infection and Immunity · doi:10.1128/iai.01560-08 · Cited by 125 · cited 1×
“It has been hypothesized that phosphorylated CovR represses the expression of certain genes (speA, hasA, and ska), while nonphosphorylated CovR represses the expression of another, distinct set of genes, including speB and grab (312).”
BackgroundBisno, A. L., & Stevens, D. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00198-3 · Cited by 125
Bricker, A. L., Cywes, C., Ashbaugh, C. D., & Wessels, M. R. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02876.x · Cited by 124
Role of Streptococcal Pyrogenic Exotoxin B in the Mouse Model of Group A Streptococcal Infection
Kuo, C.-F., Wu, J.-J., Lin, K.-Y., Tsai, P.-J., Lee, S.-C., Jin, Y., Lei, H.-Y., & Lin, Y.-S. (1998) · Infection and Immunity · doi:10.1128/iai.66.8.3931-3935.1998 · Cited by 124 · cited 1×
“full virulence in mouse models of invasive GAS disease (254, 255, 316, 321, 322), and covRS mutants of GAS are less able to establish infection due to enhanced capsule expression, which may explain the maintenance of the wild-type allele in the GAS population (323, 324).”
BackgroundTalay, S. R., Valentin‐Weigand, P., Timmis, K. N., & Chhatwal, G. S. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00448.x · Cited by 123
Fernie, B. A., Seilly, D. J., Davies, A., & Lachmann, P. J. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.4908-4916.2002 · Cited by 123
Fernie‐King, B. A., Seilly, D. J., Willers, C., Würzner, R., Davies, A., & Lachmann, P. J. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01249.x · Cited by 121 · cited 1×
“Streptococcal inhibitor of complement-mediated lysis (SIC) is a secreted 31-kDa virulence factor uniquely expressed by serotype M1 and M57 GAS strains (209) that binds and inhibits the complement C5b67 complex to prevent formation of the membrane attack complex (209, 210), which is generally ineffective against the th…”
BackgroundKaplan, E. L., & Johnson, D. R. (2001) · PEDIATRICS · doi:10.1542/peds.108.5.1180 · Cited by 121 · cited 1×
“Despite universal sensitivity to penicillin, GAS infections may fail to respond to penicillin therapy, leading to persistent throat carriage and recurrent infections (473, 474).”
BackgroundKAPLAN, E. L., JOHNSON, D. R., DEL ROSARIO, M. C., & HORN, D. L. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199912000-00008 · Cited by 121 · cited 1×
“Most advisory groups recommend penicillin as the treatment of choice for GAS pharyngitis (434, 438), because of its narrow spectrum and because GAS has remained exquisitely susceptible to -lactam drugs (439).”
BackgroundTet(M)-promoted release of tetracycline from ribosomes is GTP dependent
Burdett, V (1996) · Journal of Bacteriology · doi:10.1128/jb.178.11.3246-3251.1996 · Cited by 121 · cited 1×
“These proteins share homology with elongation factors EF-G and EF-Tu and possess GTPase activity that is important for the displacement of tetracycline from the ribosome (510, 511).”
BackgroundRheumatic Fever Following Streptococcal Vaccination
Massell, B. F. (1969) · JAMA · doi:10.1001/jama.1969.03150190037007 · Cited by 121
Streptococcal superantigens: categorization and clinical associations
Commons, R. J., Smeesters, P. R., Proft, T., Fraser, J. D., Robins-Browne, R. M., & Curtis, N. C. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.10.004 · Cited by 120 · cited 4×
“Of these superantigens, SpeG and SmeZ are chromosomally encoded, while the remaining superantigen genes are located on prophages in the GAS genome (355).”
BackgroundInfluentialKapur, V., Maffei, J. T., Greer, R. S., Li, L., Adams, G. J., & Musser, J. M. (1994) · Microbial Pathogenesis · doi:10.1006/mpat.1994.1044 · Cited by 120
Differential Recognition of Surface Proteins in Streptococcus pyogenes by Two Sortase Gene Homologs
Barnett, T. C., & Scott, J. R. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.8.2181-2191.2002 · Cited by 119 · cited 1×
“The M protein is a major surface protein and virulence factor of GAS, which is anchored to the cell wall peptidoglycan through an LPxTG motif (117, 131).”
BackgroundSelf-citationTalay, S. R., Zock, A., Rohde, M., Molinari, G., Oggioni, M., Pozzi, G., Guzman, C. A., & Chhatwal, G. S. (2000) · Cellular Microbiology · doi:10.1046/j.1462-5822.2000.00076.x · Cited by 117
Positive transcriptional control of mry regulates virulence in the group A streptococcus
Okada, N., Geist, R. T., & Caparon, M. G. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01180.x · Cited by 116
Population biology of the human restricted pathogen, Streptococcus pyogenes
Bessen, D. E. (2009) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2009.03.002 · Cited by 116 · cited 1×
“Furthermore, emm pattern E isolates are considered generalists and can be found at both tissue sites (166).”
BackgroundSjögren, J., Struwe, W. B., Cosgrave, E. F. J., Rudd, P. M., Stervander, M., Allhorn, M., Hollands, A., Nizet, V., & Collin, M. (2013) · Biochemical Journal · doi:10.1042/bj20130126 · Cited by 115 · cited 1×
“EndoS2 hydrolyzes biantennary and sialylated glycans on 1-acid glycoprotein (AGP) and all N-linked glycans on the heavy chain of IgG to impair immune effector functions (250).”
BackgroundSelf-citationDale, J. B. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00150-9 · Cited by 115 · cited 1×
“Two N-terminal M protein vaccine preparations have reached human clinical trials to date: a hexavalent preparation (444, 539, 540) and a 26-valent preparation (541, 542).”
BackgroundWessels, M. R., Goldberg, J. B., Moses, A. E., & DiCesare, T. J. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.433-441.1994 · Cited by 114
Kalia, A., & Bessen, D. E. (2003) · Journal of Bacteriology · doi:10.1128/jb.186.1.110-121.2004 · Cited by 114 · cited 2×
“Phylogenetic studies of the most divergent ska sequences have revealed two main sequence clusters (cluster types 1 and 2), with evidence of smaller subclusters observed in cluster type 2 sequences (cluster types 2a and 2b) (174, 175).”
BackgroundTerao, Y., Kawabata, S., Kunitomo, E., Nakagawa, I., & Hamada, S. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.993-997.2002 · Cited by 114 · cited 1×
“Additionally, GAS strains possess a laminin binding lipoprotein, Lbp, which plays a role in epithelial cell adherence (155).”
BackgroundYork, M. K., Gibbs, L., Perdreau-Remington, F., & Brooks, G. F. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1727-1731.1999 · Cited by 113
Molecular mechanisms underlying group A streptococcal pathogenesis
Olsen, R. J., Shelburne, S. A., & Musser, J. M. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01225.x · Cited by 113 · cited 6×
“, phospholipase), tissue-damaging enzymes released by activated host neutrophils, and a proinflammatory cytokine cascade arising from uncontrolled T-cell responses to superantigens (20, 61, 85, 282, 286).”
BackgroundInfluentialBushkin, G. G., Motari, E., Carpentieri, A., Dubey, J. P., Costello, C. E., Robbins, P. W., & Samuelson, J. C. (2013) · mBio · doi:10.1128/mbio.00387-13 · Cited by 113
Brenciani, A., Bacciaglia, A., Vecchi, M., Vitali, L. A., Varaldo, P. E., & Giovanetti, E. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01484-06 · Cited by 113
Guzmán, C. A., Talay, S. R., Molinari, G., Medina, E., & Chhatwal, G. S. (1999) · The Journal of Infectious Diseases · doi:10.1086/314655 · Cited by 113 · cited 9×
“phagocytosis by macrophages and antibody-dependent cell-mediated toxicity (240, 241).”
BackgroundInfluentialStenberg, L., O'Toole, P., & Lindahl, G. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01557.x · Cited by 112
Batsford, S., Mezzano, S. A., Mihatsch, M. J., Schiltz, E., & Rodreguez-iturbe, B. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00504.x · Cited by 111
The CsrR/CsrS two-component system of group A Streptococcus responds to environmental Mg 2+
Gryllos, I., Levin, J. C., & Wessels, M. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0636231100 · Cited by 111
Seven‐Year Surveillance of North American Pediatric Group A Streptococcal Pharyngitis Isolates
Shulman, S. T., Tanz, R. R., Dale, J. B., Beall, B., Kabat, W. J., Kabat, K., Cederlund, E., Patel, D., Rippe, J., Li, Z., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/599344 · Cited by 111
Management of common bacterial infections of the skin
Bernard, P. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f44c63 · Cited by 110
Metzgar, D., & Zampolli, A. (2011) · Virulence · doi:10.4161/viru.2.5.16342 · Cited by 110 · cited 1×
“, emm types 1, 4, 12, 49, 55, 57, and 60), and puerperal sepsis (emm type 28) (60).”
Molecular Characterization of the 2011 Hong Kong Scarlet Fever Outbreak
Tse, H., Bao, J. Y. J., Davies, M. R., Maamary, P., Tsoi, H.-W., Tong, A. H. Y., Ho, T. C. C., Lin, C.-H., Gillen, C. M., Barnett, T. C., et al. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis362 · Cited by 109 · cited 4×
“Large-scale GAS outbreaks also occur as a result of the emergence of dominant clones, which may arise through the horizontal acquisition of DNA that encodes toxins or antibiotic resistance determinants (19, 26, 40, 103), or through more subtle genetic changes (104, 105).”
BackgroundInfluentialSelf-citationCytosolic Proteins Contribute to Surface Plasminogen Recruitment of Neisseria meningitidis
Knaust, A., Weber, M. V. R., Hammerschmidt, S., Bergmann, S., Frosch, M., & Kurzai, O. (2007) · Journal of Bacteriology · doi:10.1128/jb.01966-06 · Cited by 109
Human monoclonal antibodies reactive with antigens of the group A Streptococcus and human heart.
Cunningham, M. W., McCormack, J. M., Talaber, L. R., Harley, J. B., Ayoub, E. M., Muneer, R. S., Chun, L. T., & Reddy, D. V. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.8.2760 · Cited by 108 · cited 1×
“For instance, monoclonal antibodies to streptococcal antigens were found to react with both M proteins and sections of myocardium, and the major autoantigen was found to be myosin (390, 391).”
BackgroundMarshall, C., Cheng, A. C., Markey, P. G., Towers, R. J., Richardson, L. J., Fagan, P. K., Scott, L., Krause, V., & Currie, B. J. (2011) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.11-0185 · Cited by 107 · cited 21×
“Timothy C. Barnett is currently a Senior Research Fellow at the Australian Infectious Diseases Research Centre, University of Queensland.”
BackgroundInfluentialMannam, P., Jones, K. F., & Geller, B. L. (2004) · Infection and Immunity · doi:10.1128/iai.72.6.3444-3450.2004 · Cited by 107 · cited 1×
“Protection has been observed following heterologous expression of the C-repeat region by vaccinia virus (547) and Lactococcus lactis (548).”
BackgroundRibardo, D. A., & McIver, K. S. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05381.x · Cited by 107 · cited 1×
“Mga activity has been linked to carbohydrate metabolism (143, 303, 305), and variation in the phosphorylation of Mga in response to differences in sugar availability alters Mga function (306).”
BackgroundThe epidemiology of invasive group A streptococcal disease in Victoria, Australia
O’Grady, K.-A. F., Kelpie, L., Andrews, R. M., Curtis, N. C., Nolan, T. M., Selvaraj, G., Passmore, J. W., Oppedisano, F., Carnie, J. A., & Carapetis, J. R. (2007) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01054.x · Cited by 105 · cited 6×
“The prevalence of macrolide-resistant isolates was high in Poland (42%), Hong Kong (28%), Italy (25%), Portugal (24%), and Spain (21%); low in the United States (6.9%), Australia (4%), Turkey (1.9%), Sweden (4%), and Switzerland (2.6%); and absent in Indonesia, Austria, Belgium, the Netherlands, and the United Kingdom…”
BackgroundInfluentialBernish, B. W., & van de Rijn, I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4786 · Cited by 105 · cited 1×
“The control of virulence regulatory system (covRS), also known as the capsule synthesis regulon (csrRS) (296, 307, 308), encodes a membrane-bound sensor kinase (CovS) and a DNA binding response regulator (CovR) (309).”
BackgroundPopulation Genetics and Linkage Analysis of Loci within the FCT Region ofStreptococcus pyogenes
Kratovac, Z., Manoharan, A., Luo, F. H., Lizano, S., & Bessen, D. E. (2007) · Journal of Bacteriology · doi:10.1128/jb.01301-06 · Cited by 105 · cited 2×
“Attempts have been made to identify the specific adaptations responsible for niche specialization, and several GAS genes that display strong linkage disequilibrium with the emm pattern groupings have been identified (127, 167).”
BackgroundRole of Streptolysin O in a Mouse Model of Invasive Group A Streptococcal Disease
Limbago, B. M., Penumalli, V., Weinrick, B. C., & Scott, J. R. (2000) · Infection and Immunity · doi:10.1128/.68.11.6384-6390.2000 · Cited by 105 · cited 1×
“The central importance of SLO in GAS disease pathogenesis is supported by findings that SLO mutants are attenuated for virulence in subcutaneous, intravenous, and intraperitoneal mouse models of invasive GAS disease (221, 227, 228).”
BackgroundStreptococcus pyogenes Collagen Type I-binding Cpa Surface Protein
Kreikemeyer, B., Nakata, M., Oehmcke, S., Gschwendtner, C., Normann, J., & Podbielski, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502896200 · Cited by 104 · cited 1×
“Genes with a differential presence or absence among tissue-tropic strains include cpa (encoding a type I collagen binding protein) (168), prtF1 (encoding the fibronectin binding protein PrtF1) (169), sof (encoding serum opacity factor, which contains a fibronectin binding domain) (170, 171), and prtF2 (encoding the fi…”
BackgroundBryant, A. E., Bayer, C. R., Chen, R. Y. Z., Guth, P. H., Wallace, R. J., & Stevens, D. L. (2005) · The Journal of Infectious Diseases · doi:10.1086/432729 · Cited by 104 · cited 1×
“Furthermore, for serotype M1 GAS strains, SLO has been shown to induce platelet-neutrophil aggregation (226), contributing to vascular occlusion and tissue damage in invasive disease.”
BackgroundRocha, C. L., & Fischetti, V. A. (1999) · Infection and Immunity · doi:10.1128/iai.67.6.2720-2728.1999 · Cited by 104
Kawabata, S., Kunitomo, E., Terao, Y., Nakagawa, I., Kikuchi, K., Totsuka, K.-I., & Hamada, S. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.924-930.2001 · Cited by 103 · cited 2×
“Non-M-protein antigens that have been tested in animal models include fibronectin binding protein A (FbaA) (564), protein F1/SfbI (240), serum opacity factor (SOF/SfbII) (565), fibronectin binding protein 54 (FBP54) (566), R28 protein (567, 568), streptococcal protective antigen (Spa) (569), C5a peptidase (ScpA) (570–…”
BackgroundAcquisition of Regulators of Complement Activation by Streptococcus pyogenes Serotype M1
Pandiripally, V., Gregory, E., & Cue, D. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6206-6214.2002 · Cited by 102 · cited 1×
“FbaA binds the human complement-regulatory proteins factor H and FHL-1, preventing the deposition of C3b on the GAS cell surface, and promotes survival in whole human blood (218).”
BackgroundDiagnosis and treatment of impetigo.
Cole, C., & Gazewood, J. D. (2007) · PubMed · Cited by 101
Kaplan, E. L., Chhatwal, G. S., & Rohde, M. (2006) · Clinical Infectious Diseases · doi:10.1086/508773 · Cited by 101
DNase Sda1 Allows Invasive M1T1 Group A Streptococcus to Prevent TLR9-Dependent Recognition
Uchiyama, S., Andreoni, F., Schuepbach, R. A., Nizet, V., & Zinkernagel, A. S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002736 · Cited by 101
Self-citationProtection Against Streptococcal Pharyngeal Colonization with a Vaccinia: M Protein Recombinant
Fischetti, V. A., Hodges, W. M., & Hruby, D. E. (1989) · Science · doi:10.1126/science.2660266 · Cited by 101 · cited 1×
“Protection has been observed following heterologous expression of the C-repeat region by vaccinia virus (547) and Lactococcus lactis (548).”
BackgroundFrick, I., Mörgelin, M., & Björck, L. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02084.x · Cited by 100 · cited 1×
“Furthermore, the M1 protein promotes interbacterial aggregation to enhance bacterial adherence to and invasion of epithelial cells (147).”
BackgroundHollands, A., Pence, M. A., Timmer, A. M., Osvath, S. R., Turnbull, L., Whitchurch, C. B., Walker, M. J., & Nizet, V. (2010) · The Journal of Infectious Diseases · doi:10.1086/653124 · Cited by 100 · cited 1×
“full virulence in mouse models of invasive GAS disease (254, 255, 316, 321, 322), and covRS mutants of GAS are less able to establish infection due to enhanced capsule expression, which may explain the maintenance of the wild-type allele in the GAS population (323, 324).”
BackgroundSelf-citationShikhman, A. R., Greenspan, N. S., & Cunningham, M. W. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3902 · Cited by 99 · cited 2×
“However, immunological crossreactivity between anti-GAC antibodies and host heart valve proteins (563) and cytoskeletal proteins, such as actin, keratin, myosin, and vimentin (392), raises important potential safety concerns regarding the use of GAC as a GAS vaccine constituent.”
BackgroundAshbaugh, C. D., Moser, T. J., Shearer, M. H., White, G. L., Kennedy, R. C., & Wessels, M. R. (2000) · Cellular Microbiology · doi:10.1046/j.1462-5822.2000.00050.x · Cited by 99 · cited 1×
“The GAS capsule blocks antibody access to surface epitopes (200), inhibits complement deposition (188), promotes resistance to opsonophagocytosis (188, 189), enhances survival within neutrophil extracellular traps (NETs) (201), and is necessary for full virulence in mouse (202–205) and nonhuman primate (206) models of…”
BackgroundPotter, E. V., Lipschultz, S. A., Abidh, S., Poon-King, T., & Earle, D. P. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209163071205 · Cited by 99 · cited 1×
“Urinalysis results are normal for 95% of patients 15 years following the acute episode (466).”
BackgroundMACRIS, M. H., Hartman, N., MURRAY, B., Klein, R. F., Roberts, R. B., Kaplan, E. L., HORN, D., & Zabriskie, J. B. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199805000-00006 · Cited by 99 · cited 1×
“The penicillin susceptibility of GAS has not altered significantly in over 50 years of use of penicillin as a treatment for GAS infection (467).”
BackgroundBruun, T., Kittang, B. R., de Hoog, B. J., Aardal, S., Flaatten, H. K., Langeland, N., Mylvaganam, H., Vindenes, H., & Skrede, S. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12276 · Cited by 98
De novo formation of focal complex‐like structures in host cells by invading Streptococci
Ozeri, V., Rosenshine, I., Ben‐Ze'Ev, A., Bokoch, G. M., Jou, T., & Hanski, E. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02535.x · Cited by 98 · cited 2×
“Focal adhesion kinase (FAK); integrin-linked kinase (ILK); Rac; CDC42; and the Src kinases Src, Yes, and Fyn have also been shown to be involved in 5 1-mediated GAS internalization (144, 156).”
BackgroundHytönen, J., Haataja, S., Gerlach, D., Podbielski, A., & Finne, J. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02269.x · Cited by 97 · cited 1×
“Streptococcal pyrogenic exotoxin B (SpeB) is a broad-spectrum cysteine protease secreted by most GAS isolates (251) from late logarithmic to stationary phase (252).”
BackgroundBiological properties of a Streptococcus pyogenes mutant generated by Tn916 insertion in mga
Kihlberg, B., Cooney, J. C., Caparon, M. G., Olsén, A., & Björck, L. (1995) · Microbial Pathogenesis · doi:10.1016/s0882-4010(96)80003-9 · Cited by 97 · cited 2×
“The role of Mga in GAS virulence has been demonstrated in numerous models of GAS disease, including several invasive disease models (143, 305).”
BackgroundUse of the plasminogen activation system by microorganisms
Coleman, J. L., & Benach, J. L. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90095-1 · Cited by 97 · cited 1×
“Sequestration of the proteolytic activity of plasmin by GAS can facilitate fibrinolysis, thus promoting the release of bacteria from a formed clot or preventing clot formation (328, 329).”
BackgroundStreptococcal M proteins and their role as virulence determinants
Oehmcke-Hecht, S., Shannon, O., Mörgelin, M., & Herwald, H. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.04.032 · Cited by 97
Ogawa, T., Terao, Y., Okuni, H., Ninomiya, K., Sakata, H., Ikebe, K., Maeda, Y., & Kawabata, S. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.03.009 · Cited by 96 · cited 1×
“It has been suggested that GAS may escape penicillin treatment by entering epithelial cells, which are poorly penetrated by penicillin (475–477), or by forming a biofilm (478, 479), or alternatively, failure of penicillin treatment may possibly be due to the protection of GAS by other -lactamase-producing bacterial sp…”
BackgroundPapageorgiou, A. C., Collins, C. M., Gutman, D. M., Kline, J. B., O'Brien, S. M., Tranter, H. S., & Acharya, K. R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.9 · Cited by 96
Emergence of Macrolide-Resistant Streptococcus pyogenes Strains in French Children
Bingen, É., Bidet, P., Mihaïla-Amrouche, L., Doit, C., Forcet, S., Brahimi, N., Bouvet, A., & Cohen, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3559-3562.2004 · Cited by 96 · cited 1×
“A rapid increase in the percentage of macrolide-resistant strains may also be due to the clonal expansion of a single resistant strain (442, 498, 504).”
BackgroundBarg, N. L. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.257 · Cited by 95
LENNON, D. R., Farrell, E., Martin, D., & Stewart, J. M. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2006.113506 · Cited by 95 · cited 1×
“Several antimicrobial agents, including clarithromycin, cefuroxime, and cefixime, can successfully eradicate GAS from the pharynx when administered for 5 days (446, 447), and effective eradication with once-daily dosing has been described for amoxicillin, azithromycin, and various cephalosporins (448, 449).”
BackgroundCARAPETIS, J. R., WALKER, A. M., HIBBLE, M., SRIPRAKASH, K. S., & CURRIE, B. J. (1999) · Epidemiology and Infection · doi:10.1017/s0950268898001952 · Cited by 94 · cited 1×
“5 per 100,000 [87–89]), Africa (13.”
Self-citationNyberg, P., Rasmussen, M., & Björck, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400485200 · Cited by 94
Hamilton, S. M., Stevens, D. L., & Bryant, A. E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit282 · Cited by 94
Lipoteichoic acid and M protein: dual adhesins of group A streptococci
Courtney, H. S., von Hunolstein, C., Dale, J. B., Bronze, M. S., Beachey, E. H., & Hasty, D. L. (1992) · Microbial Pathogenesis · doi:10.1016/0882-4010(92)90054-r · Cited by 93
Staali, L., Bauer, S., Mörgelin, M., Björck, L., & Tapper, H. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00662.x · Cited by 93
A decade of molecular pathogenomic analysis of group A Streptococcus
Musser, J. M., & Shelburne, S. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38095 · Cited by 93 · cited 1×
“There are approximately 13 two-component regulatory systems (TCSs) and 100 putative standalone transcriptional regulators in the GAS genomes sequenced to date (34, 35, 39, 293).”
BackgroundShannon, O., Hertzén, E., Norrby‐Teglund, A., Mörgelin, M., Sjöbring, U., & Björck, L. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05841.x · Cited by 93 · cited 1×
“Soluble M protein also mediates platelet activation and aggregation in vitro (383), which may contribute to the aggregated platelet deposition seen in invasive GAS infections (383, 384).”
BackgroundNooh, M. M., El-Gengehi, N., Kansal, R. G., David, C. S., & Kotb, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3076 · Cited by 93 · cited 2×
“Epidemiologically, host major histocompatibility complex (MHC) class II haplotype DR11/DQ3 is associated with necrotizing fasciitis, while haplotype DR3/DQ2 may protect against disease (289, 290).”
BackgroundFox, E. N., Waldman, R. H., Wittner, M. K., Mauceri, A. A., & Dorfman, A. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107372 · Cited by 93
Cantón, R., Loza, E., Morosini, M. I., & Baquero, F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf811 · Cited by 92
Polly, S. M., Waldman, R. H., High, P., Wittner, M., Dorfman, A., & Fox, E. N. (1975) · The Journal of Infectious Diseases · doi:10.1093/infdis/131.3.217 · Cited by 91
Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses
Bronze, M. S., Courtney, H. S., & Dale, J. B. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.3.888 · Cited by 90
Sitkiewicz, I., Nagiec, M. J., Sumby, P., Butler, S. D., Cywes‐Bentley, C., & Musser, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607669103 · Cited by 90
Vlaminckx, B. J. M., Mascini, E. M., Schellekens, J. F. P., Schouls, L. M., Paauw, A., Fluit, A. C., Novak, R., Verhoef, J., & Schmitz, F. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.4941-4949.2003 · Cited by 90
Fisher, M., Huang, Y.-S., Li, X., McIver, K. S., Toukoki, C., & Eichenbaum, Z. (2008) · Infection and Immunity · doi:10.1128/iai.00300-08 · Cited by 90 · cited 1×
“These adhesins include M proteins (serotypes M1, M3, and M6) (135, 141), protein H (151), GAPDH (152), the hemoprotein binding protein Shr, and the collagen-like protein Scl1, which can bind both fibronectin and laminin (153, 154).”
BackgroundTissue Tropisms in Group a Streptococcal Infections
Bessen, D. E., & Lizano, S. (2010) · Future Microbiology · doi:10.2217/fmb.10.28 · Cited by 90 · cited 1×
“, certain emm types have a strong tendency to cause throat infection but not superficial skin infection, while other emm types are often recovered from cases of impetigo but rarely from cases of pharyngitis (164).”
BackgroundBessen, D. E., Manoharan, A., Luo, F. H., Wertz, J. E., & Robinson, D. A. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.12.4163-4172.2005 · Cited by 90 · cited 2×
“Attempts have been made to identify the specific adaptations responsible for niche specialization, and several GAS genes that display strong linkage disequilibrium with the emm pattern groupings have been identified (127, 167).”
BackgroundSimpson, W. J., LaPenta, D., Chen, C., & Cleary, P. P. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.2.696-700.1990 · Cited by 89
Matta, S. K., Agarwal, S., & Bhatnagar, R. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.08.004 · Cited by 89
Hoe, N. P., Ireland, R. M., DeLeo, F. R., Gowen, B. B., Dorward, D. W., Voyich, J. M., Liu, M., Burns, E. H., Culnan, D. M., Bretscher, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112039899 · Cited by 89 · cited 1×
“SIC also contributes to epithelial cell adherence (211) and mucosal colonization (212) and binds innate immune factors, including secretory leukocyte protease inhibitor, lysozyme, human -defensin-1, and human cathelicidin antimicrobial peptide LL-37 (213– 215).”
BackgroundSanderson‐Smith, M. L., Dowton, M., Ranson, M., & Walker, M. J. (2007) · Journal of Bacteriology · doi:10.1128/jb.01218-06 · Cited by 88
Self-citationChaussee, M. S., Phillips, E. R., & Ferretti, J. J. (1997) · Infection and Immunity · doi:10.1128/iai.65.5.1956-1959.1997 · Cited by 88 · cited 1×
“Streptococcal pyrogenic exotoxin B (SpeB) is a broad-spectrum cysteine protease secreted by most GAS isolates (251) from late logarithmic to stationary phase (252).”
BackgroundDinkla, K., Rohde, M., Jansen, W. T. M., Carapetis, J. R., Chhatwal, G. S., & Talay, S. R. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03352.x · Cited by 87 · cited 1×
“This endothelial damage in ARF patients exposes valve collagen, which, on its own or after aggregating on ARF-associated GAS isolates, elicits elevated anticollagen responses (396, 397).”
BackgroundFrick, I., Schmidtchen, A., & Sjöbring, U. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03600.x · Cited by 87 · cited 1×
“Additionally, the M6 protein binds directly to ligands present on host cells, such as the keratinocyte membrane cofactor CD46 (145), and the M1 protein can bind to surface-expressed glycosaminoglycans, including dermatan sulfate, heparan sulfate, and heparin (146).”
BackgroundM protein mediates streptococcal adhesion to HEp-2 cells
Wang, J. R., & Stinson, M. W. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.442-448.1994 · Cited by 87
Shelburne, S. A., Granville, C., Tokuyama, M., Sitkiewicz, I., Patel, P., & Musser, J. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.4723-4731.2005 · Cited by 86 · cited 2×
“The characterized ability of GAS to overcome the innate and acquired immune mechanisms present in saliva allows the bacterium to remain viable for long periods (112), permitting transmission from infected persons or asymptomatic carriers via respiratory droplets.”
BackgroundWhatmore, A. M. (2001) · Microbiology · doi:10.1099/00221287-147-2-419 · Cited by 86
Chang, A., Khemlani, A., Kang, H., & Proft, T. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07550.x · Cited by 85
Anti‐phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M‐related protein
Courtney, H. S., Hasty, D. L., & Dale, J. B. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04977.x · Cited by 85 · cited 2×
“M-protein- and Mrp-mediated (182) fibrinogen bind-”
Ekelund, K., Darenberg, J., Norrby‐Teglund, A., Hoffmann, S., Bang, D., Skinhøj, P., & Konradsen, H. B. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3101-3109.2005 · Cited by 85 · cited 1×
“These types are also the types most commonly isolated from asymptomatic carriers (43).”
BackgroundCleary, P. P., Matsuka, Y. V., Huynh, T., Lam, H., & Olmsted, S. B. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.04.030 · Cited by 85
Kurupati, P., Turner, C. E., Tziona, I., Lawrenson, R. A., Alam, F. M., Nohadani, M., Stamp, G. W., Zinkernagel, A. S., Nizet, V., Edwards, R. J., et al. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07065.x · Cited by 85
Self-citationPérez‐Trallero, E., Montes, M., Orden, B., Tamayo, E. H., García-Arenzana, J. M., & Marimón, J. M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01054-06 · Cited by 85
Recombinant, octavalent group A streptococcal M protein vaccine
Dale, J. B., Simmons, M., Chiang, E. C., & Chiang, E. Y. (1996) · Vaccine · doi:10.1016/0264-410x(96)00050-3 · Cited by 84
Human kininogens interact with M protein, a bacterial surface protein and virulence determinant
Nasr, A. B., Herwald, H., Müller‐Esterl, W., & Björck, L. (1995) · Biochemical Journal · doi:10.1042/bj3050173 · Cited by 83 · cited 2×
“Kininogen binding has been demonstrated for the M1, M6, and M46 proteins (374).”
BackgroundA microbial platform for rapid and low-cost virus-like particle and capsomere vaccines
Middelberg, A. P. J., Rivera-Hernández, T., Wibowo, N., Lua, L. H. L., Fan, Y., Magor, G. W., Chang, C. J., Chuan, Y. P., Good, M. F., & Batzloff, M. R. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.075 · Cited by 83
Varaldo, P. E., Debbia, E. A., Nicoletti, G., Pavesio, D., Ripa, S., Schito, G. C., Tempera, G., & the Artemis‐Italy Study Group (1999) · Clinical Infectious Diseases · doi:10.1086/520451 · Cited by 83
Stollerman, G. H., & Dale, J. B. (2008) · Clinical Infectious Diseases · doi:10.1086/529194 · Cited by 83
Insight of Host Immune Evasion Mediated by Two Variants of Group A Streptococcus Mac Protein
Agniswamy, J., Lei, B., Musser, J. M., & Sun, P. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410698200 · Cited by 82 · cited 1×
“Mac-2, a related IgG endopeptidase, binds Fc receptors and prevents the recognition of IgG bound to GAS by host phagocytes (246).”
BackgroundSvensson, M. D., Scaramuzzino, D. A., Sjöbring, U., Olsén, A., Frank, C., & Bessen, D. E. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02144.x · Cited by 82 · cited 2×
“full virulence in mouse models of invasive GAS disease (254, 255, 316, 321, 322), and covRS mutants of GAS are less able to establish infection due to enhanced capsule expression, which may explain the maintenance of the wild-type allele in the GAS population (323, 324).”
BackgroundVoyich, J. M., Braughton, K. R., Sturdevant, D. E., Vuong, C., Kobayashi, S. D., Porcella, S. F., Otto, M., Musser, J. M., & DeLeo, F. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1194 · Cited by 82 · cited 2×
“Inactivation of this system in an M6 background significantly reduces GAS virulence in a mouse model of bacteremia (298).”
BackgroundFittipaldi, N., Beres, S. B., Olsen, R. J., Kapur, V., Shea, P. R., Watkins, M. E., Cantu, C. C., Laucirica, D. R., Jenkins, L., Flores, A. R., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.12.037 · Cited by 82 · cited 1×
“Large-scale GAS outbreaks also occur as a result of the emergence of dominant clones, which may arise through the horizontal acquisition of DNA that encodes toxins or antibiotic resistance determinants (19, 26, 40, 103), or through more subtle genetic changes (104, 105).”
BackgroundRole of fibrinogen in complement inhibition by streptococcal M protein
Horstmann, R. D., Sievertsen, H. J., Leippe, M., & Fischetti, V. A. (1992) · Infection and Immunity · doi:10.1128/iai.60.12.5036-5041.1992 · Cited by 81
Caswell, C. C., Barczyk, M., Keene, D. R., Lukomska, E., Gullberg, D. E., & Lukomski, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806865200 · Cited by 81
McKay, F. C., McArthur, J. D., Sanderson‐Smith, M. L., Gardam, S., Currie, B. J., Sriprakash, K. S., Fagan, P. K., Towers, R. J., Batzloff, M. R., Chhatwal, G. S., et al. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.364-370.2004 · Cited by 81 · cited 4×
“Serotype M1T1 GAS is the most frequently isolated serotype from severe invasive human infections worldwide (103), but strains of non-M1 serotypes also cause invasive GAS infections (319, 320).”
BackgroundInfluentialSelf-citationWang, B., Yurecko, R. S., Dedhar, S., & Cleary, P. P. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00618.x · Cited by 80 · cited 2×
“Focal adhesion kinase (FAK); integrin-linked kinase (ILK); Rac; CDC42; and the Src kinases Src, Yes, and Fyn have also been shown to be involved in 5 1-mediated GAS internalization (144, 156).”
BackgroundΦm46.1, the Main Streptococcus pyogenes Element Carrying mef (A) and tet (O) Genes
Brenciani, A., Bacciaglia, A., Vignaroli, C., Pugnaloni, A., Varaldo, P. E., & Giovanetti, E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00499-09 · Cited by 80
STUDIES ON THE PATHOGENICITY OF GROUP A STREPTOCOCCI
Foley, M. J., & Wood, W. B. (1959) · The Journal of Experimental Medicine · doi:10.1084/jem.110.4.617 · Cited by 80
D’Alessandri, R. M., Plotkin, G. R., Kluge, R., Wittner, M., Fox, E. N., Dorfman, A., & Waldman, R. H. (1978) · The Journal of Infectious Diseases · doi:10.1093/infdis/138.6.712 · Cited by 80
Multiple binding of type 3 streptococcal M protein to human fibrinogen, albumin and fibronectin
Schmidt, K. (1993) · FEMS Immunology and Medical Microbiology · doi:10.1016/0928-8244(93)90063-a · Cited by 79 · cited 3×
“For GAS strains that do not possess high-affinity plasminogen binding proteins but do express fibrinogen binding proteins such as PrtF1 and PrtF2 variants (349), M protein variants (141), and the lipoprotein Spy0591 (350), this mechanism of plasmin acquisition may be central to plasminogen-mediated virulence.”
BackgroundSandin, C., Carlsson, F., & Lindahl, G. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04913.x · Cited by 79 · cited 1×
“c One or more M types can be associated with a specific FCT variant, but strains belonging to a specific M type carry the same FCT region (184).”
BackgroundTurner, C. E., Kurupati, P., Wiles, S., Edwards, R. J., & Sriskandan, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.042 · Cited by 79
Miyoshi‐Akiyama, T., Takamatsu, D., Koyanagi, M., Zhao, J., Imanishi, K., & Uchiyama, T. (2005) · The Journal of Infectious Diseases · doi:10.1086/430617 · Cited by 79 · cited 1×
“SLS is an oxygen-stable cytolytic toxin that enhances GAS resistance to phagocytosis by forming hydrophilic pores in neutrophil cell membranes (231).”
BackgroundShet, A., Kaplan, E. L., Johnson, D. R., & Cleary, P. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/377700 · Cited by 79
Svensson, M. D., Sjöbring, U., Luo, F. H., & Bessen, D. E. (2002) · Microbiology · doi:10.1099/00221287-148-12-3933 · Cited by 78 · cited 1×
“For GAS strains that express a plasminogen binding M protein, targeted elimination of plasminogen binding reduces the capacity of GAS to cause lethal infection in the humanized plasminogen mouse model (258, 325, 342).”
BackgroundCue, D. R., Lam, H., & Cleary, P. P. (2001) · Microbial Pathogenesis · doi:10.1006/mpat.2001.0467 · Cited by 78 · cited 1×
“M proteins (M1, M3, and M6) may promote bacterial colonization by binding directly to components of the ECM, such as fibronectin (140, 141).”
BackgroundFernie‐King, B. A., Seilly, D. J., & Lachmann, P. J. (2004) · Immunology · doi:10.1111/j.0019-2805.2004.01837.x · Cited by 78
Group A Streptococcus emm Gene Types in Pharyngeal Isolates, Ontario, Canada, 2002–2010
Shea, P. R., Ewbank, A. L., Gonzalez-Lugo, J. H., Martagón, A. J., Martínez-Gutiérrez, J. C., Rehman, H., Gonzalez, M. S., Fittipaldi, N., Beres, S. B., Flores, A. R., et al. (2011) · Emerging infectious diseases · doi:10.3201/eid1711.110159 · Cited by 77 · cited 1×
“Examples include the association of emm types 1, 3, and 49 with invasive disease and emm types 2, 4, 6, 12, and 44/61 with superficial disease (46, 58, 59).”
BackgroundRogers, S., Commons, R., Danchin, M. H., Selvaraj, G., Kelpie, L., Curtis, N., Robins‐Browne, R., & Carapetis, J. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/513875 · Cited by 77 · cited 1×
“The isolation frequency for emm types from different GAS diseases generally parallels their rate of asymptomatic carriage in the same population (57).”
BackgroundCytolysin-dependent evasion of lysosomal killing
Håkansson, A., Bentley, C. C., Shakhnovic, E. A., & Wessels, M. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408721102 · Cited by 76 · cited 1×
“SLO expression facilitates GAS escape from the endosome after host cell invasion (223) and reduces host tumor necrosis factor alpha (TNF- ) and interleukin-1 (IL-1 ) inflammatory cytokine responses, promoting virulence in mouse models of GAS invasive disease (221).”
BackgroundFritzer, A., Senn, B. M., Minh, D. B., Hanner, M., Gelbmann, D., Noiges, B., Henics, T., Schulze, K., Guzmán, C. A., GOODACRE, J. A., et al. (2010) · Infection and Immunity · doi:10.1128/iai.00295-10 · Cited by 76 · cited 2×
“This approach yielded 6 conserved antigens, including SpyCEP, each of which elicited protection against intranasal and intravenous challenge (587).”
BackgroundHall, M. A., Stroop, S. D., Hu, M. C., Walls, M. A., Reddish, M. A., Burt, D. S., Lowell, G. H., & Dale, J. B. (2004) · Infection and Immunity · doi:10.1128/iai.72.5.2507-2512.2004 · Cited by 76
Smeesters, P. R., Mardulyn, P., Vergison, A., Leplae, R., & Melderen, L. V. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.037 · Cited by 75
Morfeldt, E., Berggård, K., Persson, J., Drakenberg, T., Johnsson, E., Lindahl, E. R., Linse, S. S., & Lindahl, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3870 · Cited by 75
Sanderson-Smith, M. L., Dinkla, K., Cole, J. N., Cork, A. J., Maamary, P. G., McArthur, J. D., Chhatwal, G. S., & Walker, M. J. (2008) · The FASEB Journal · doi:10.1096/fj.07-105643 · Cited by 74 · cited 3×
“For GAS strains that express a plasminogen binding M protein, targeted elimination of plasminogen binding reduces the capacity of GAS to cause lethal infection in the humanized plasminogen mouse model (258, 325, 342).”
BackgroundSelf-citationEpitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium
Baird, R., Bronze, M. S., Kraus, W., Hill, H. R., Veasey, L. G., & Dale, J. B. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.3132 · Cited by 74 · cited 1×
“However, epitopes shared between GAS M proteins and antigens in cartilage and synovium (415) suggest a role for autoimmunity in poststreptococcal reactive arthritis.”
BackgroundHollands, A., Aziz, R. K., Kansal, R. G., Kotb, M., Nizet, V., & Walker, M. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004102 · Cited by 74 · cited 3×
“Less frequently, mutations in the standalone regulator ropB (alternatively known as rgg) have also been identified in invasive GAS isolates (316, 317).”
BackgroundSelf-citationYamaguchi, M., Terao, Y., & Kawabata, S. (2012) · Cellular Microbiology · doi:10.1111/cmi.12083 · Cited by 73 · cited 2×
“When fibronectin binds to MSCRAMMs, it undergoes a conformational change which exposes an RGD motif allowing it to interact with the 5 1 integrin (149) and results in integrin clustering and the formation of focal complexes on the host cell surface (156), followed by internalization into the endocytic pathway via a “z…”
BackgroundPTS phosphorylation of Mga modulates regulon expression and virulence in the group A streptococcus
Hondorp, E. R., Hou, S. C., Hause, L. L., Gera, K., Lee, C., & McIver, K. S. (2013) · Molecular Microbiology · doi:10.1111/mmi.12250 · Cited by 72 · cited 3×
“The inhibition of Mga phosphorylation significantly decreased virulence in a mouse model of invasive infection (306), and thus, the ability to modulate Mga activity appears to contribute to invasive disease initiation.”
BackgroundStructure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A Streptococcus
Henningham, A., Ericsson, D. J., Langer, K., Casey, L. W., Jovcevski, B., Chhatwal, G. S., Aquilina, J. A., Batzloff, M. R., Kobe, B., & Walker, M. J. (2013) · mBio · doi:10.1128/mbio.00509-13 · Cited by 72 · cited 3×
“Non-M-protein antigens that have been tested in animal models include fibronectin binding protein A (FbaA) (564), protein F1/SfbI (240), serum opacity factor (SOF/SfbII) (565), fibronectin binding protein 54 (FBP54) (566), R28 protein (567, 568), streptococcal protective antigen (Spa) (569), C5a peptidase (ScpA) (570–…”
BackgroundSelf-citationRecombinant tetravalent group A streptococcal M protein vaccine.
Dale, J. B., Chiang, E. Y., & Lederer, J. W. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2188 · Cited by 71
Towards a Vaccine Against Rheumatic Fever
Guilherme, L., Fae, K. C., Higa, F. T., Chaves, L., Oshiro, S. E., Barros, S. F., Puschel, C. R., Juliano, M. A., Tanaka, A. C., Spina, G. S., et al. (2006) · Journal of Immunology Research · doi:10.1080/17402520600877026 · Cited by 71
Salvadori, L. G., Blake, M. S., McCarty, M., Tai, J. Y., & Zabriskie, J. B. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.3.593 · Cited by 71 · cited 1×
“Affinity-purified anti-GAC antibodies successfully opsonized three tested GAS serotypes (561), and mice immunized with GAC were protected against both intraperitoneal and intranasal GAS challenge (562).”
BackgroundDiagnosis and management of cellulitis
Phoenix, G., Das, S. K., & Joshi, M. (2012) · BMJ · doi:10.1136/bmj.e4955 · Cited by 71
Ashbaugh, C. D., Albertí, S., & Wessels, M. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.18.4955-4959.1998 · Cited by 70 · cited 2×
“The third gene in the operon, hasC, is not essential for GAS capsule biosynthesis (196, 197).”
BackgroundCytolysins Augment Superantigen Penetration of Stratified Mucosa
Brosnahan, A. J., Mantz, M. J., Squier, C. A., Peterson, M. L., & Schlievert, P. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803283 · Cited by 70 · cited 2×
“SLO has also been shown to facilitate penetration of stratified squamous cell mucosa by superantigens (225), enhancing the level of SLO-associated tissue damage during infection.”
BackgroundTyrrell, G. J., Lovgren, M., Forwick, B. A., Hoe, N. P., Musser, J. M., & Talbot, J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.12.4466-4471.2002 · Cited by 69
Conserved anchorless surface proteins as group A streptococcal vaccine candidates
Henningham, A., Chiarot, E., Gillen, C. M., Cole, J. N., Rohde, M., Fulde, M., Ramachandran, V., Cork, A. J., Hartas, J., Magor, G. W., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0897-9 · Cited by 69
Self-citationArdanuy, C., Domenech, A., Rolo, D., Calatayud, L., Tubau, F., Ayats, J., Martin, R., & Liñares, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq006 · Cited by 69
Alam, F. M., Turner, C. E., Smith, K. C., Wiles, S., & Sriskandan, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061655 · Cited by 68
Dale, J. B., Seyer, J. M., & Beachey, E. H. (1983) · The Journal of Experimental Medicine · doi:10.1084/jem.158.5.1727 · Cited by 68
Siemens, N., Patenge, N., Otto, J., Fiedler, T., & Kreikemeyer, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202671 · Cited by 67 · cited 1×
“Plasminogen bound to the GAS cell surface can interact with keratinocytes via the cell-exposed integrins 1 1 and 5 1 (137).”
BackgroundAto, M., Ikebe, T., Kawabata, H., Takemori, T., & Watanabe, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003455 · Cited by 66 · cited 1×
“The central importance of SLO in GAS disease pathogenesis is supported by findings that SLO mutants are attenuated for virulence in subcutaneous, intravenous, and intraperitoneal mouse models of invasive GAS disease (221, 227, 228).”
BackgroundPark, H., & Cleary, P. P. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.7878-7886.2005 · Cited by 66
The extracellular hyaluronidase gene (hylA) of Streptococcus pyogenes
Hynes, W. L., Dixon, A. R., Walton, S. L., & Aridgides, L. J. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb08999.x · Cited by 66 · cited 1×
“GAS emm 4 and emm 22 strains lack the hasABC operon, are nonencapsulated (207), and express a hyaluronic acid-degrading enzyme, hyaluronate lyase (HylA) (208).”
BackgroundCaswell, C. C., Oliver-Kozup, H., Han, R., Lukomska, E., & Lukomski, S. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01864.x · Cited by 66 · cited 1×
“These adhesins include M proteins (serotypes M1, M3, and M6) (135, 141), protein H (151), GAPDH (152), the hemoprotein binding protein Shr, and the collagen-like protein Scl1, which can bind both fibronectin and laminin (153, 154).”
BackgroundFrick, I.-M., Crossin, K. L., Edelman, G. M., & Björck, L. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07156.x · Cited by 65 · cited 1×
“These adhesins include M proteins (serotypes M1, M3, and M6) (135, 141), protein H (151), GAPDH (152), the hemoprotein binding protein Shr, and the collagen-like protein Scl1, which can bind both fibronectin and laminin (153, 154).”
BackgroundIdentification of a Streptococcal Octapeptide Motif Involved in Acute Rheumatic Fever
Dinkla, K., Nitsche-Schmitz, D. P., Barroso, V., Reißmann, S., Johansson, H. M., Frick, I.-M., Rohde, M., & Chhatwal, G. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701047200 · Cited by 65 · cited 1×
“Interestingly, these antibodies are distinct populations from anti-M-protein antibodies (398) and hence are not likely to be cross-reactive.”
BackgroundJansen, T. L. T. A., Janssen, M., Jong, A. J. L., & Jeurissen., M. E. C. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.0438e.x · Cited by 65
Flores, A. R., Jewell, B. E., Fittipaldi, N., Beres, S. B., & Musser, J. M. (2012) · mBio · doi:10.1128/mbio.00413-12 · Cited by 65 · cited 2×
“GAS emm 4 and emm 22 strains lack the hasABC operon, are nonencapsulated (207), and express a hyaluronic acid-degrading enzyme, hyaluronate lyase (HylA) (208).”
BackgroundInvasive group A streptococcal disease in North Queensland (1996 - 2001).
Norton, R. E., Smith, H. V., Wood, N., Siegbrecht, E., Ross, A., & Ketheesan, N. (2004) · PubMed · Cited by 64
Research works printed but not linked: 3
- Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470–511. 10.1128/CMR.13.3.470-511.2000 [DOI] [PMC free article] [PubMed] [Google Scholar] · doi:10.1128/cmr.13.3.470-511.2000 · Paper page
- WHO. 2005. The current evidence for the burden of group A streptococcal diseases. WHO report. WHO, Geneva, Switzerland [Google Scholar]
- American Academy of Pediatrics. 2012. Group A streptococcal infections, p 668–680 In Pickering LK, Baker CJ, Kimberlin DW, Long SS. (ed), Red book: 2012 report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village, IL [Google Scholar]
Cited by
The wound microbiota: microbial mechanisms of impaired wound healing and infection
Uberoi, A., McCready-Vangi, A., & Grice, E. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01035-z · Cited by 864
“Interestingly, most adhesin proteins are not present universally across all GAS strains and it is thought that expression and/or regulation of adhesins plays a role in determining tissue tropism of GAS bacteria 79 .”
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T.-D. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 438
Pathogenesis, epidemiology and control of Group A Streptococcus infection
Brouwer, S., Rivera-Hernandez, T., Curren, B. F., Harbison-Price, N., De Oliveira, D. M. P., Jespersen, M. G., Davies, M. R., & Walker, M. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00865-7 · Cited by 374
Self-citationEmerging and Neglected Infectious Diseases: Insights, Advances, and Challenges
Nii-Trebi, N. I. (2017) · BioMed Research International · doi:10.1155/2017/5245021 · Cited by 356
“By understanding the dynamics of disease and the means of contracting it, methods of fighting, preventing, and controlling are developed [2, 5, 6].”
Lawrence, J. G., Carapetis, J. R., Griffiths, K., Edwards, K., & Condon, J. R. (2013) · Circulation · doi:10.1161/circulationaha.113.001477 · Cited by 282
Metadata
- Authors
- Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V.
- Affiliations
- The University of Queensland (AU)
- University of Wollongong (AU)
- QIMR Berghofer Medical Research Institute (AU)
- School of Biological Sciences and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia
- University of California San Diego (US)
- Corresponding author
- Walker, Mark J.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2014-04
- Volume
- 27
- Issue
- 2
- Pages
- 264-301
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC3993104
- OpenAlex
- W2145736155
- Cited by
- 908
- References
- 626
- Citations by year
- 2026: 74 · 2025: 85 · 2024: 96 · 2023: 81 · 2022: 82 · 2021: 87 · 2020: 91 · 2019: 76 · 2018: 57 · 2017: 59 · 2016: 55 · 2015: 50 · 2014: 12
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI077780)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052728)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Keywords
- Streptococcus pyogenes, virulence factors, pathogenesis, pharyngitis, impetigo, necrotizing fasciitis, toxic shock syndrome, post-streptococcal glomerulonephritis, rheumatic fever, rheumatic heart disease, innate immune evasion, tissue degradation, antibiotic resistance, streptococcal vaccine, disease progression model
- MeSH terms
- Animals, Anti-Bacterial Agents, Disease Models, Animal, Humans, Streptococcal Infections, Streptococcus pyogenes, Virulence, Streptococcal Vaccines, Drug Resistance, Bacterial, Virulence Factors, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.